NCT00955916
- Conditions
- Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +15 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Clinical trial condition
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.
309 public trials
17 recruiting studies
Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results
NCT00003572
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +46 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
NCT00003960
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
- Center for Cancer Treatment and Research Columbia, South Carolina, United States
NCT01231919
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, +130 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Childrens Hospital of Orange County Orange, California, United States
- University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
NCT00265837
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT01233921
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
NCT00890747
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
- Locations
-
- Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
- Northwestern University Chicago, Illinois, United States
- AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
NCT00004145
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +52 more
- Locations
-
- University of Chicago Cancer Research Center Chicago, Illinois, United States
NCT00538850
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +260 more
- Locations
-
- InSys Therapeutics, Incorporated Chandler, Arizona, United States
NCT00438958
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +61 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
- Institute of Medical and Veterinary Science Adelaide, South Australia, Australia
- Royal Melbourne Hospital Parkville, Victoria, Australia
- Vancouver Hospital and Health Science Center Vancouver, British Columbia, Canada